Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ: BLAC · IEX Real-Time Price · USD
Bellevue Life Sciences Acquisition currently trades with the ticker symbol BLACU
10.10
-0.01 (-0.10%)
Mar 28, 2023, 4:00 PM EDT - Market closed
Company Description
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington.
Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Bellevue Life Sciences Acquisition Corp.
| Country | United States |
| Founded | 2020 |
| IPO Date | Feb 10, 2023 |
| Industry | Shell Companies |
| Sector | Financials |
Contact Details
Address:
10900 Ne 4th Street, Suite 2300 Bellevue, Washington 98004 United States | |
| Phone | 425-635-7700 |
Stock Details
| Ticker Symbol | BLAC |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001840425 |
| Employer ID | 84-5052822 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 14, 2023 | 8-K | Current Report |
| Feb 28, 2023 | 8-K | Current Report |
| Feb 21, 2023 | 8-K | Current Report |
| Feb 16, 2023 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 15, 2023 | 8-K | Current Report |
| Feb 13, 2023 | 424B4 | Prospectus |
| Feb 9, 2023 | EFFECT | Notice of Effectiveness |
| Feb 9, 2023 | CERT | Certification by an exchange approving securities for listing |
| Feb 8, 2023 | 8-A12B/A | Filing |
| Jan 20, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |